Concepedia

Varuna Nangia

VN

10

Publications

1.4K

Citations

10

H-Index

2018

Active since

Affiliations

Massachusetts General Hospital(Current)

Harvard University

University of Colorado Anschutz Medical Campus

Johnson University

University of Colorado Boulder

Varuna Nangia is an author at Massachusetts General Hospital specializing in medicine, cell biology, and tumor biology.

ORCID

Top concepts

Publications per year

2018–2023

10

Publications

10

Landscape of Acquired Resistance to Osimertinib in <i>EGFR</i> -Mutant NSCLC and Clinical Validation of Combined EGFR and RET Inhibition with Osimertinib and BLU-667 for Acquired <i>RET</i> Fusion

Zofia Piotrowska, Hideko Isozaki, Jochen K. Lennerz et al. · Cancer Discovery · 2018 · 434 citations

KRAS G12C NSCLC Models Are Sensitive to Direct Targeting of KRAS in Combination with PI3K Inhibition

Sandra Misale, Jackson P. Fatherree, Eliane Cortez et al. · Clinical Cancer Research · 2018 · 253 citations

Targeting FGFR overcomes EMT-mediated resistance in EGFR mutant non-small cell lung cancer

Sana Raoof, Iain J. Mulford, Heidie Frisco Cabanos et al. · Oncogene · 2019 · 207 citations · Full text

, , +8

Rapid adaptation to CDK2 inhibition exposes intrinsic cell-cycle plasticity

Mansi Arora, Justin Moser, Timothy E. Hoffman et al. · Cell · 2023 · 158 citations

, , +6

Therapy-induced APOBEC3A drives evolution of persistent cancer cells

Hideko Isozaki, Ramin Sakhtemani, Ammal Abbasi et al. · Nature · 2023 · 130 citations · Full text

, , +4

Rows per page

1–5 of 10